Personal information

Activities

Employment (4)

Hospital Universitario de la Princesa: Madrid, Madrid, ES

2020-08-01 to present | Postdoctoral researcher (Fundación de Investigación Sanitaria Hospital Universitario La Princesa, Immunology Service)
Employment
Source: Self-asserted source
Silvia Requena Galindo

Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana: Majadahonda, Madrid, ES

2015-01-02 to 2018-12-31 | PhD student/researcher (Internal Medicine Laboratory )
Employment
Source: Self-asserted source
Silvia Requena Galindo

Hospital Universitario Clínico San Carlos: Madrid, ES

2014-01-15 to 2014-06-30 | Master researcher/student (Immunology Service)
Employment
Source: Self-asserted source
Silvia Requena Galindo

Umea Universitet Institutionen for Molekylarbiologi: Umea, SE

2013-01-15 to 2013-06-20 | Bachelor degree thesis researcher/student (Molecular Biology)
Employment
Source: Self-asserted source
Silvia Requena Galindo

Education and qualifications (4)

Universidad Autónoma de Madrid: Madrid, Madrid, ES

2015-01-02 to 2019-09-13 | PhD programme on Molecular Biosciences
Education
Source: Self-asserted source
Silvia Requena Galindo

Universidad Complutense de Madrid: Madrid, Comunidad de Madrid, ES

2013-09-09 to 2014-07-10 | Research on Immunology
Education
Source: Self-asserted source
Silvia Requena Galindo

Umea Universitet: Umea, SE

2012-08-15 to 2013-06-20 | Erasmus fellowship: Tumour Biology, Computational Life Science and Bachelor degree thesis in Molecular Biology
Education
Source: Self-asserted source
Silvia Requena Galindo

Universidad de Alcalá de Henares Facultad de Biología Ciencias Ambientales y Química: Alcala de Henares, Madrid, ES

2009-09-05 to 2013-06-20 | Healthy Biology
Education
Source: Self-asserted source
Silvia Requena Galindo

Professional activities (2)

Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica: Madrid, ES

2016-03-04 to present
Membership
Source: Self-asserted source
Silvia Requena Galindo

International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 2018: Marseille, Provence Alpes Côte d'Azur, FR

2018-05-18 | Best presented poster Award, to the work entitled: High Rate of HIV-1 Coinfection in HIV-2 West African Immigrants Living in Spain (International Symposium)
Distinction
Source: Self-asserted source
Silvia Requena Galindo

Funding (1)

PFIS contract

Contract
Instituto de Salud Carlos III (Madrid, ES)
Source: Self-asserted source
Silvia Requena Galindo

Works (14)

Chaperonin CCT controls extracellular vesicle production and cell metabolism through kinesin dynamics

Journal of Extracellular Vesicles
2023-06 | Journal article
Contributors: Amelia Rojas‐Gómez; Sara G. Dosil; Francisco J. Chichón; Nieves Fernández‐Gallego; Alessia Ferrarini; Enrique Calvo; Diego Calzada‐Fraile; Silvia Requena; Joaquin Otón; Alvaro Serrano et al.
Source: check_circle
Crossref

Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain.

AIDS (London, England)
2019-11-01 | Journal article
Source: Self-asserted source
Silvia Requena Galindo

Infección por VIH-2 en España: aspectos epidemiológicos y respuesta al tratamiento con inhibidores de la integrasa

2019-09-13 | Dissertation or Thesis
Source: Self-asserted source
Silvia Requena Galindo

Benefits of hepatitis C cure with antivirals: why test and treat?

Future microbiology
2019-03-22 | Journal article
Source: Self-asserted source
Silvia Requena Galindo

Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain.

The Journal of antimicrobial chemotherapy
2019-02-11 | Journal article
Source: Self-asserted source
Silvia Requena Galindo

Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfection.

AIDS (London, England)
2018-10-01 | Journal article
Source: Self-asserted source
Silvia Requena Galindo

Treatment and prevention of HIV infection with long-acting antiretrovirals.

Expert review of clinical pharmacology
2018-03-29 | Journal article
Source: Self-asserted source
Silvia Requena Galindo

Baseline NS5A resistance associated substitutions may impair DAA response in real-world hepatitis C patients.

Journal of medical virology
2017-11-03 | Journal article
Source: Self-asserted source
Silvia Requena Galindo

Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response.

The Journal of antimicrobial chemotherapy
2017-07-01 | Journal article
Source: Self-asserted source
Silvia Requena Galindo

Human T-lymphotropic virus type 1 infection and disease in Spain.

AIDS (London, England)
2017-07-01 | Journal article
Source: Self-asserted source
Silvia Requena Galindo

HIV type 2 epidemic in Spain: challenges and missing opportunities.

AIDS (London, England)
2017-06-01 | Journal article
Source: Self-asserted source
Silvia Requena Galindo

HTLV infection in HCV-antibody positive patients in Spain.

AIDS research and human retroviruses
2017-03-07 | Journal article
Source: Self-asserted source
Silvia Requena Galindo

Impact of ITPA gene polymorphisms on the risk of ribavirin-induced haemolytic anaemia using interferon-free antivirals for chronic hepatitis C.

Antiviral therapy
2017-02-15 | Journal article
Source: Self-asserted source
Silvia Requena Galindo

Drug-Induced Lung Injury in a Liver Transplant Patient Treated With Sofosbuvir.

Transplantation proceedings
2016-09-01 | Journal article
Source: Self-asserted source
Silvia Requena Galindo